Other authors have also linked germline SNPs, such as PDCD1 rs2227981 with a lower risk of treatment-related toxicity of any grade in non-small cell lung cancer patients receiving anti-PD1 nivolumab treatment [30]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.